Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains. Issue 1 (1st January 2019)

• Record Type: Journal Article
• Authors: Wei, Wenjing; Yan, Huimin; Zhao, Jiao; Li, Haicheng; Li, Zhenyan; Guo, Huixin; Wang, Xuezhi; Zhou, Ying; Zhang, Xiaoli; Zeng, Jincheng; Chen, Tao; Zhou, Lin
• Is Part Of: Emerging microbes & infections. Volume 8:Issue 1(2019)
• Page Start: 248
• Page End: 261
• Publication Date: 2019-01-01
• Subjects: P-Aminosalicylic acid -- multi-omics -- Mycobacterium tuberculosis -- folC; Medical microbiology -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 616.9041
• DOI: 10.1080/22221751.2019.1568179
• Languages: English
• ISSNs: 2222-1751

Abstract

ABSTRACT: p -Aminosalicylic acid (PAS) is an important second-line antibiotic for treating multidrug-resistant tuberculosis (MDR-TB). Due to gastrointestinal disturbance and intolerance, its potent and efficacy in the treatment of extensively drug-resistant (XDR)-TB commonly are poor. Thus, it is important to reveal the mechanism of susceptibility and resistance of Mycobacterium tuberculosis (Mtb) to this drug. Herein, we screened and established PAS-resistant (PAS r ) folC mutated and un-mutated Mtb strains, then utilized a multi-omics (genome, proteome, and metabolome) analysis to better characterize the mechanisms of PAS resistance in Mtb. Interestingly, we found that promotion of SAM-dependent methyltransferases and suppression of PAS uptake via inhibiting some drug transport associated membrane proteins were two key pathways for the folC mutated strain evolving into the PAS r Mtb strain. However, the folC un-mutated strain was resistant to PAS via uptake of exogenous methionine, mitigating the role of inhibitors, and promoting DfrA, ThyA and FolC expression. Beyond these findings, we also found PAS resistance in Mtb might be associated with the increasing phenylalanine metabolism pathway. Collectively, our findings uncovered the differences of resistant mechanism between folC mutated and un-mutated Mtb strains resistant to PAS using multi-omics analysis and targeting modulators to these pathways may be effective for treatment of PAS r Mtb strains.